The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
1,2,3‐Triazole hybrids as anticancer agents: A review
Abstract
Despite the advancements in the development of anticancer agents, more effective and safer anticancer drugs still need to be developed as the current agents cause unwanted side effects and many patients have become drug resistant. 1,2,3‐Triazoles, due to their remarkable biological potential, have received considerable attention in drug discovery for the development of anticancer agents. The present review article presents an overview of the recent advances in 1,2,3‐triazole hybrids with anticancer potential over the last 2 years, their chemical structures, structure–activity relationships, and mechanisms of action, as well as insights into the docking studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Microtubules as a target for anticancer drugs
Jordan, M. A., & Wilson, L. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1317 · Cited by 4,000
Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors
Sequist, L. V., Waltman, B. A., Dias-Santagata, D., Digumarthy, S., Turke, A. B., Fidias, P., Bergethon, K., Shaw, A. T., Gettinger, S., Cosper, A. K., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002003 · Cited by 3,499
Schirrmacher, V. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4661 · Cited by 1,296
1,2,3-Triazole-containing hybrids as leads in medicinal chemistry: A recent overview
Bozorov, K., Zhao, J., & Aisa, H. A. (2019) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2019.07.005 · Cited by 854
The Role of Carbonic Anhydrase in Photosynthesis
Badger, M. (1994) · Annual Review of Plant Physiology and Plant Molecular Biology · doi:10.1146/annurev.arplant.45.1.369 · Cited by 816
The epidermal growth factor receptor family: Biology driving targeted therapeutics
Wieduwilt, M. J., & Moasser, M. M. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7440-8 · Cited by 751
The 1,2,3-triazole ring as a bioisostere in medicinal chemistry
Bonandi, E., Christodoulou, M. S., Fumagalli, G., Perdicchia, D., Rastelli, G., & Passarella, D. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.05.014 · Cited by 743
Nepali, K., Sharma, S., Sharma, M., Bedi, P. M. S., & Dhar, K. L. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.03.018 · Cited by 435
Recent Developments in Targeting Carbonic Anhydrase IX for Cancer Therapeutics
McDonald, P. C., Winum, J.-Y., Supuran, C. T., & Dedhar, S. (2012) · Oncotarget · doi:10.18632/oncotarget.422 · Cited by 421
Shafi, S., Mahboob Alam, M., Mulakayala, N., Mulakayala, C., Vanaja, G., Kalle, A. M., Pallu, R., & Alam, M. S. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.01.032 · Cited by 301
Self-citationTriazole: A Promising Antitubercular Agent
Keri, R. S., Patil, S. A., Budagumpi, S., & Nagaraja, B. M. (2015) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12527 · Cited by 187
Caspase-Independent Cell Death by Arsenic Trioxide in Human Cervical Cancer Cells
Kang, Y.-H., Yi, M.-J., Kim, M.-J., Park, M.-T., Bae, S., Kang, C.-M., Cho, C.-K., Park, I.-C., Park, M.-J., Rhee, C. H., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1830 · Cited by 183
Mahdy, H. A., Ibrahim, M. K., Metwaly, A. M., Belal, A., Mehany, A. B. M., El-Gamal, K. M. A., El-Sharkawy, A., Elhendawy, M. A., Radwan, M. M., Elsohly, M. A., et al. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.103422 · Cited by 171
Ali, A. A.-S., Khan, D. J. O., Naqvi, A., Al-blewi, F. F., Rezki, N., Aouad, M. R., & Hagar, M. (2020) · ACS Omega · doi:10.1021/acsomega.0c04595 · Cited by 141
Estriol acts as a GPR30 antagonist in estrogen receptor-negative breast cancer cells
Lappano, R., Rosano, C., Marco, P. D., Francesco, E. M. D., Pezzi, V., & Maggiolini, M. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.02.006 · Cited by 137
Rezki, N., Almehmadi, M. A., Ihmaid, S. K., Shehata, A. M., Omar, A. M., Ahmed, H. E. A., & Aouad, M. R. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.104133 · Cited by 104
Ashour, H. F., Abou-zeid, L. A., El‐Sayed, M. A. ‐., & Selim, K. B. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112062 · Cited by 95
Wang, D.-P., Liu, K.-L., Li, X., Lu, G., Xue, W.-H., Qian, X.-H., Olounfeh, K. M., & Meng, F. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.113083 · Cited by 89
Guo, C., Wang, L., Li, X., Wang, S., Yu, X., Xu, K., Zhao, Y., Luo, J., Li, X., Jiang, B., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01946 · Cited by 87
Uracil-coumarin based hybrid molecules as potent anti-cancer and anti-bacterial agents
Sanduja, M., Gupta, J., Singh, H., Pagare, P. P., & Rana, A. (2019) · Journal of Saudi Chemical Society · doi:10.1016/j.jscs.2019.12.001 · Cited by 79
Novel VEGFR-2 kinase inhibitors identified by the back-to-front approach
Sanphanya, K., Wattanapitayakul, S. K., Phowichit, S., Fokin, V. V., & Vajragupta, O. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.03.042 · Cited by 78
Ihmaid, S. K., Al‐Raqa, S. Y., Aouad, M. R., Aljuhani, A., Elbadawy, H. M., Salama, S. A., Rezki, N., & Ahmed, H. E. A. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.104835 · Cited by 77
5-Amino-2-Aroylquinolines as Highly Potent Tubulin Polymerization Inhibitors
Nien, C.-Y., Chen, Y.-C., Kuo, C., Hsieh, H., Chang, C.-Y., Wu, J., Wu, S., Liou, J., & Chang, J. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm900685y · Cited by 76
Khattab, R. R., Alshamari, A. K., Hassan, A. A., Elganzory, H. H., El‐Sayed, W. A., Awad, H. M., Nossier, E. S., & Hassan, N. A. (2021) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2020.1871335 · Cited by 75
Fu, D., Li, P., Wu, B., Cui, X., Zhao, C., & Zhang, S. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.01.033 · Cited by 73
Alam, M. M., Malebari, A. M., Nazreen, S., Neamatallah, T., Almalki, A. S. A., Elhenawy, A. A., Obaid, R. J., & Alsharif, M. A. (2021) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2021.116136 · Cited by 72
Self-citationAlzhrani, Z. M. M., Alam, M. M., Neamatallah, T., & Nazreen, S. (2020) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2020.1759581 · Cited by 69
Self-citationAlam, M. M., Almalki, A. S. A., Neamatallah, T., Ali, N. M., Malebari, A. M., & Nazreen, S. (2020) · Pharmaceuticals · doi:10.3390/ph13110390 · Cited by 60
Self-citationNovel antifungal agents: a patent review (2013 - present)
Castelli, M. V., Derita, M., & López, S. N. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2017.1261113 · Cited by 55
Damghani, T., Moosavi, F., Khoshneviszadeh, M., Mortazavi, M., Pirhadi, S., Kayani, Z., Saso, L., Edraki, N., & Firuzi, O. (2021) · Scientific Reports · doi:10.1038/s41598-021-83069-4 · Cited by 52
Al‐Raqa, S. Y., Alharbi, K., Aljuhani, A., Rezki, N., Aouad, M. R., & Ali, I. (2020) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2020.129192 · Cited by 51
Hachim, M. E., Oubella, A., Byadi, S., Fawzi, M., Laamari, Y., Bahsis, L., Aboulmouhajir, A., Morjani, H., Podlipnik, Č., Auhmani, A., et al. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.1894984 · Cited by 48
Qi, Z.-Y., Hao, S.-Y., Tian, H.-Z., Bian, H., Hui, L., & Chen, S. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.103392 · Cited by 46
1,2,3-Triazoles as inhibitors of indoleamine 2,3-dioxygenase 2 (IDO2)
Röhrig, U. F., Majjigapu, S. R., Caldelari, D., Dilek, N., Reichenbach, P., Ascenção, K., Irving, M. B., Coukos, G., Vogel, P., Zoete, V., et al. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.07.031 · Cited by 42
Li, S., Li, X., Zhang, T., Zhu, J., Xue, W.-H., Qian, X.-H., & Meng, F. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.103575 · Cited by 40
Meščić, A., Perin, N., Jakopec, S., Mioč, M., Stojković, M. R., Kralj, M., Hranjec, M., & Raić‐Malić, S. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111845 · Cited by 39
Pan, S., Zhou, Y., Wang, Q., Wang, Y., Tian, C., Wang, T., Huang, L., Nan, J., Li, L., & Yang, S. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112703 · Cited by 39
Fu, D., Yang, J., Li, P., Hou, Y.-H., Huang, S., Tippin, M., Pham, V., Song, L., Zi, X., Xue, W.-L., et al. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.07.060 · Cited by 37
Curcumin-1,2,3-Triazole Conjugation for Targeting the Cancer Apoptosis Machinery
Seghetti, F., Martino, R. M. C. D., Catanzaro, E., Bisi, A., Gobbi, S., Rampa, A., Canonico, B., Montanari, M., Krysko, D. V., Papa, S., et al. (2020) · Molecules · doi:10.3390/molecules25133066 · Cited by 35
Grymel, M., Pastuch-Gawołek, G., Lalik, A., Zawojak, M., Boczek, S., Krawczyk, M., & Erfurt, K. (2020) · Molecules · doi:10.3390/molecules25246019 · Cited by 33
Hao, S., Cheng, X., Wang, X., An, R., Xu, H., Guo, M., Li, C., Wang, Y., Hou, Z., & Guo, C. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.104237 · Cited by 31
Popov, S. A., Semenova, M. D., Baev, D. S., et al. (2020) · Steroids · doi:10.1016/j.steroids.2020.108698 · Cited by 30
Menta, E., & Palumbo, M. (1997) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.7.12.1401 · Cited by 27
Lan, T. T., Anh, D. T., Pham‐The, H., Dung, D. T. M., Hương, L. T. T., Park, E. J., Jeon, H. W., Kang, J. S., Thuần, N. T. D., Han, S., et al. (2019) · Medicinal Chemistry Research · doi:10.1007/s00044-019-02488-1 · Cited by 26
The Antioxidant and Antiproliferative Activities of 1,2,3-Triazolyl-L-Ascorbic Acid Derivatives
Harej, A., Meščić, A., Stepanić, V., Klobučar, M., Pavelić, K., Pavelić, S. K., & Raić‐Malić, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194735 · Cited by 23
Silalai, P., Sirion, U., Piyachaturawat, P., Chairoungdua, A., Suksen, K., & Saeeng, R. (2020) · ChemistrySelect · doi:10.1002/slct.202001908 · Cited by 21
Baraniak, D., Baranowski, D., Ruszkowski, P., & Boryski, J. (2019) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770.2019.1610891 · Cited by 20
Khazir, J., Mir, B. A., Chashoo, G., Pilcher, L. A., & Riley, D. L. (2019) · Medicinal Chemistry Research · doi:10.1007/s00044-019-02456-9 · Cited by 20
Design, synthesis and antitumor activity of icotinib derivatives
Mao, L., Sun, G., Zhao, J., Xu, G., Yuan, M., & Li, Y. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.104421 · Cited by 20
de Andrade, P., Dias, A. D. F., Figueiró, F., Torres, F., Kawano, D. F., Battastini, A. M. O., Carvalho, I., da Silva, C. H. T. D. P., & Rosa, J. M. C. (2020) · Future Medicinal Chemistry · doi:10.4155/fmc-2019-0227 · Cited by 18
Sonego, M. S., Segatto, N. V., Damé, L., Fronza, M. G., Gomes, C. B., Oliveira, T. L., Seixas, F. K., Savegnago, L., Schachtschneider, K. M., Alves, D. A. C., et al. (2019) · Investigational New Drugs · doi:10.1007/s10637-019-00861-w · Cited by 16
A Novel Series of N-aryltriazole and N-acridinyltriazole Hybrids as Potential Anticancer Agents
Rono, C. K., Darkwa, J., Meyer, D., & Makhubela, B. C. E. (2019) · Current Organic Synthesis · doi:10.2174/1570179416666190704112904 · Cited by 10
Lan, T. T., Anh, D. T., Pham‐The, H., Dung, D. T. M., Park, E. J., Jang, S. D., Kwon, J. H., Kang, J. S., Thuần, N. T. D., Han, S., et al. (2020) · Chemistry & Biodiversity · doi:10.1002/cbdv.202000290 · Cited by 9
Fakhree, A. A., Ghasemi, Z., Rahimi, M., & Shahrisa, A. (2020) · Applied Organometallic Chemistry · doi:10.1002/aoc.5773 · Cited by 9
Krishna, R., Sridhar, G. L. V. N., & Jayaprakash, H. V. (2020) · Russian Journal of General Chemistry · doi:10.1134/s1070363220050242 · Cited by 9
Novel aryltriazole acyclic C -azanucleosides as anticancer candidates
Zhang, Y., Lin, Y., Hou, Q., Liu, X., Pricl, S., Peng, L., & Xia, Y. (2020) · Organic & Biomolecular Chemistry · doi:10.1039/d0ob02164d · Cited by 9
Metadata
- Authors
- Alam, M. M.
- Venue
- Archiv der Pharmazie
- Publisher
- Wiley
- Published
- 2021-09-24
- Volume
- 355
- Issue
- 1
- Pages
- e2100158-e2100158
- ISSN
- 0365-6233 (ISSN-L)
- 1521-4184
- OpenAlex
- W3199081935
- Cited by
- 312
- References
- 56
- FWCI
- 18.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.